TITLE
PBMCs from CCI-779 Treated RCC subjects

ORGANISM
Homo sapiens

SUMMARY
Clinical Pharmacogenomics study. Renal Cell Carcinoma subjects were treated with CCI-779 and peripheral blood mononuclear cells were profiled over time of treatment. Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomics responses in patients with advanced renal cancer. Clin Pharm Therapeutics Dec 2004 Keywords: other

PLATFORM
GPL91 [HG_U95A] Affymetrix Human Genome U95A Array GPL8300 [HG_U95Av2] Affymetrix Human Genome U95 Version 2 Array

CITATIONS
15637533

